Veracyte, Inc.
VCYT
$32.13
$1.203.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 115.02% | 2,052.76% | -113.91% | 37.83% | -66.26% |
| Total Depreciation and Amortization | 0.61% | -4.06% | 2.37% | -14.25% | 6.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.29% | -49.86% | 234.25% | -50.96% | 88.49% |
| Change in Net Operating Assets | -14.14% | 420.39% | 107.97% | -300.03% | -4,126.37% |
| Cash from Operations | 17.49% | 33.19% | 526.73% | -78.14% | -18.15% |
| Capital Expenditure | -35.39% | -117.11% | 29.30% | 56.07% | -84.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -97.66% | 4,707.44% | 102.12% | 0.00% | -- |
| Cash from Investing | -111.25% | 21,645.98% | 99.57% | 4.29% | -2,314.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -39.39% | 219.24% | -38.86% | -9.10% | -73.82% |
| Repurchase of Common Stock | -30.03% | -18.24% | 74.82% | -188.67% | -50.18% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -105.01% | 625.97% | 91.27% | -43.77% | -143.83% |
| Foreign Exchange rate Adjustments | -80.00% | -89.53% | 674.32% | 118.45% | -374.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -51.05% | 187.70% | 163.16% | -53.11% | -190.49% |